News

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?
Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of ...
The rapid adoption of GLP-1 receptor agonists has fundamentally altered obesity management, with these medications now ...
For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a ...
Drugmaker Eli Lilly says their oral, daily GLP-1 pill, orforglipron, may offer similar weight loss results as weekly GLP-1 ...
The FDA said it's taking action to protect patients from unapproved animal-derived thyroid medications and expressed concern over the use of unapproved GLP-1 receptor agonists for weight loss, such as ...
Eli Lilly’s GLP-1 pill helped some participants lose up to 15% body weight. But is it as effective as the injection? Here's ...
Discover how GLP-1 medications and the MAHA movement are driving protein consumption and creating new opportunities for ...
GLP-1 weight-loss drugs have already taken the Europe storm, altering consumer eating habits. Even the eating habits of GLP-1 ...
GLP-1 Drugs: Demand Surges in a Long-Established Market The market for GLP-1 drugs is projected to exceed $200 billion in annual sales by 2031, according to Morningstar Equity Research.